Research progress in radiotherapy combined with immunotherapy for non-small cell lung cancer

Radiotherapy is the common traditional treatment for non-small cell lung cancer (NSCLC). In recent years, remarkable advances have been made in immunotherapy, especially the use of immune checkpoint inhibitors. How to effectively combine radiotherapy and immunotherapy to maximize the benefit for patients has become a hot topic in clinical research. This article expounds recent research progress in immunotherapy for NSCLC, the effect of radiotherapy on tumor immunology, and the advances and challenges in radiotherapy combined with immunotherapy for NSCLC. Key words: Carcinoma, non-small cell lung/radiotherapy; Carcinoma, non-small cell lung/immunotherapy; Research progress